Q2 2025 Earnings Call Transcript August 12, 2025 Acumen Pharmaceuticals, Inc. misses on earnings expectations. Reported EPS is $-0.68 EPS, expectations were $-0.54. Operator: Good day, and welcome to ...

Sanofi’s shift to immunology, AI-driven R&D, and strong pipeline offset risks from patent cliffs and legal issues. See why ...

Europe is grappling with a growing threat from arboviruses—diseases transmitted by mosquitoes, ticks, and sandflies—as i ...

Christopher Cano has been picked as the new Chief Executive Officer of Cellergy Pharma Inc., a preclinical biotechnology firm ...

PLC (NASDAQ:SMX), a company transforming supply chain transparency through technology that links physical products to ...

ASP Isotopes Inc. NASDAQ: ASPI ("ASP Isotopes" or the "Company"), an advanced materials company dedicated to the development of technology and processes ...